Efficacy of a basal insulin dose management smartphone application for controlling fasting blood glucose in patients with type‐2 diabetes mellitus: A single‐centre, randomised clinical study
Authors' conclusion
The use of this weight-based insulin dose titration protocol for BI app is effective and safe for achieving the target FBG in noncritically ill patients with T2DM and is free, easy to use and user friendly.
Study context
- Population
- Hospitalised patients with T2DM on basal-prandial insulin therapy, Binhaiwan Central Hospital of Dongguan, December 2021–December 2022; titrated to fasting blood glucose (FBG) <7.0 mmol/L
- Participants
- 173 patients
- Comparison
- 'Walk with you' app vs typical adjustment regimen
- Appn = 87
- Controln = 86reference
Methodological detailssingle-centre, open-label
- Single-centre
- Open-label
Primary result
As reported in the abstract
Time to reach target FBG (FBG-TRT)
P < 0.001
Further findings
Decrease in FBG
Reached target FBG within 3 days
Safety
- No significant between-group difference in hypoglycaemia incidence
Original publication
Efficacy of a basal insulin dose management smartphone application for controlling fasting blood glucose in patients with type‐2 diabetes mellitus: A single‐centre, randomised clinical study. Clin Endocrinol (Oxf). Published 1 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →